Carlsmed, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Michael John Cordonnier, with a market cap of $259.8M.
Common questions about Carlsmed, Inc. Common Stock
Carlsmed, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $14.7M.
We use cookies for analytics. See our Privacy and Cookie Policy.